- Home
- AVTX vs XYF Comparison
AVTX vs XYF Comparison
Compare AVTX & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVTX | XYF |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.3M | 260.6M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AVTX | XYF |
|---|---|---|
| Price | $15.79 | $6.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $32.29 | N/A |
| AVG Volume (30 Days) | ★ 258.0K | 208.5K |
| Earning Date | 11-06-2025 | 11-20-2025 |
| Dividend Yield | N/A | ★ 9.36% |
| EPS Growth | N/A | ★ 49.84 |
| EPS | N/A | ★ 5.72 |
| Revenue | $192,000.00 | ★ $1,106,908,607.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.05 |
| Revenue Growth | N/A | ★ 47.14 |
| 52 Week Low | $3.39 | $5.44 |
| 52 Week High | $20.72 | $20.36 |
Technical Indicators
Market Signals| Indicator | AVTX | XYF |
|---|---|---|
| Relative Strength Index (RSI) | 43.42 | 40.34 |
| Support Level | $14.52 | $5.68 |
| Resistance Level | $17.12 | $6.15 |
| Average True Range (ATR) | 1.23 | 0.28 |
| MACD | -0.11 | 0.11 |
| Stochastic Oscillator | 39.72 | 30.19 |
Price Performance
Historical ComparisonAbout AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.